Search
rituximab/cyclophosphamide/doxorubicin/vincristine (Oncocin)/prednisone (R-CHOP)
Indications:
- chemotherapy regimen for treatment of lymphomas
Dosage:
- six 21-day cycles
- rituximab (375 mg/m2) administered on day 1 of each cycle
- on days 1-5
- cyclophosphamide (400 mg/m2)
- doxorubicin (25 mg/m2)
- vincristine (1 mg capped dose)
- prednisone (40 mg/m2)
Related
rituximab/cyclophosphamide/doxorubicin/vincristine (Oncocin)/dexamethasone (R-CVAD)
General
antineoplastic combination (combination chemotherapy)
References
- Peyrade F et al.
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly
patients older than 80 years with diffuse large B-cell lymphoma:
A multicentre, single-arm, phase 2 trial.
Lancet Oncol 2011 May; 12:460
http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(11)70069-9/fulltext
Components
cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271]
doxorubicin (Adriamycin, Rubex)
prednisone (Deltasone, Orasone, Liquid Pred, Meticortin, Rayos)
rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni)
vincristine; 22-oxovincaleukoblastine; leurocristine (Oncovin, Vincasar PFS)